| Phase III trial of everolimus in metastatic renal cell carcinoma: Subgroup ... - UroToday |
|
|
UroToday To assess the efficacy and safety of everolimus in Japanese patients with metastatic renal cell carcinoma. A subgroup analysis of the pivotal Phase III, |